BRAF V600E Antibody IHC

BRAF V600E Antibody IHC
This antibody is intended for in vitro diagnostic (IVD) use.
 
The BRAF V600E (IHC600) antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods. Use of this antibody is indicated, subsequent to clinical differential diagnoses of diseases, as an aid in the identification of mutant BRAF protein expression in diverse cancers within the context of antibody panels, the patient’s clinical history and other diagnostic tests evaluated by a qualified pathologist.
 
Serine/threonine-protein kinase B-Raf (BRAF) is  a  cytoplasmic serine-threonine kinase of the RAF family which mediates downstream cellular responses to growth signals through the mitogen-activated protein kinase (MAPK) signaling pathway. Oncogenic mutations in the BRAF gene, 80% of which are a single V600E substitution within the kinase domain, constitutively activate the MAPK signaling pathway and result in increased cell proliferation and apoptosis resistance. The V600E mutation is observed in colorectal cancer, non-Hodgkin lymphoma, papillary thyroid carcinoma, malignant melanoma, non-small-cell lung carcinoma, and lung adenocarcinoma. BRAF V600E is therefore an important immunohistochemical marker for tumor diagnosis and prognosis.

Write a review

    Bad           Good

Protocol
786-1421
786-1422
786-1423
Catalog Description Size Price(USD) Qty
786-1421
IHC Ab: BRAF-V600E 0.1ml
$168.00
786-1422
IHC Ab: BRAF-V600E 1ml
$735.00
786-1423
IHC Ab: BRAF-V600E 5ml
$3,200.00